Miguel Conde, MD, is a board-certified hematologist and medical oncologist at The Cancer Center at Cooperman Barnabas Medical Center.
Dr. Conde has a strong interest in clinical trials and partners with a variety of organizations including UCLA Trio (Translational Research in Oncology), National Cancer Institute (NCI), The Rutgers Cancer Institute of New Jersey and pharmaceutical companies to bring cutting edge trials and drug development to The Cancer Center at Cooperman Barnabas Medical Center.
Prior to arriving at Cooperman Barnabas, Dr. Conde was a reviewer at the U.S. Food and Drug Administration (FDA). Dr. Conde received his medical degree from Columbia University College of Physicians & Surgeons in New York City. He continued his postdoctoral training with an internship and residency in internal medicine, and a hematology/medical oncology fellowship, at George Washington University Medical Center in Washington, DC. He subsequently completed a drug development fellowship jointly sponsored by the National Cancer Institute and the FDA. Dr. Conde acquired additional training on the bone marrow transplant service at Johns Hopkins Hospital in Baltimore, Maryland.
Dr. Conde is a member of several professional organizations including the American Society of Hematology, Society for Neuro-Oncology, American College of Physicians, American Society of Clinical Oncology, and the American Medical Association.
Clinical Interests
Lymphoma, Brain Tumors, Head & Neck Cancer, Myeloma
Medical School
Columbia School of Physicians & Surgeons, New York, NY, 1986
Internship
George Washington University, Washington DC, 1987
Residency
George Washington University, Washington DC, 1989
Fellowship
George Washington University, Washington DC, 1992, National Cancer Institute/FDA, 1992
Insurance
Accepted Health Plan information is only as accurate as the most current
information submitted. Prior to your appointment, it is advisable to verify
with a physician office that they are still a participating provider.
